Real‐world experience with Grazoprevir/Elbasvir in the treatment of previously “difficult to treat” patients infected with hepatitis C virus genotype 1 and 4

2020 ◽  
Vol 35 (7) ◽  
pp. 1238-1246 ◽  
Author(s):  
Dorota Zarębska‐Michaluk ◽  
Jerzy Jaroszewicz ◽  
Iwona Buczyńska ◽  
Krzysztof Simon ◽  
Beata Lorenc ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Real World ◽  
Genotype 1 ◽  
Virus Genotype

scholarly journals Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study

Clinics ◽  
2017 ◽  
Vol 72 (6) ◽  
pp. 378-385 ◽  
Author(s):  
LA Callefi ◽  
CA Villela-Nogueira ◽  
SB Tenore ◽  
D Carnaúba-Júnior ◽  
HS Coelho ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Protease Inhibitors ◽  
Multicenter Study ◽  
Real World ◽  
First Generation ◽  
Genotype 1 ◽  
Virus Genotype

scholarly journals Real-world effectiveness of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in patients with hepatitis C virus genotype 1 or 4 infection: A meta-analysis

2017 ◽  
Vol 24 (11) ◽  
pp. 936-943 ◽  
Author(s):  
H. Wedemeyer ◽  
A. Craxí ◽  
E. Zuckerman ◽  
D. Dieterich ◽  
R. Flisiak ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Real World ◽  
Meta Analysis ◽  
Genotype 1 ◽  
Virus Genotype

scholarly journals Real‐world efficacy of elbasvir and grazoprevir for hepatitis C virus (genotype 1): A nationwide, multicenter study by the Japanese Red Cross Hospital Liver Study Group

2019 ◽  
Vol 49 (10) ◽  
pp. 1114-1120 ◽  
Author(s):  
Toshie Mashiba ◽  
Kouji Joko ◽  
Masayuki Kurosaki ◽  
Hironori Ochi ◽  
Chitomi Hasebe ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Multicenter Study ◽  
Real World ◽  
Red Cross ◽  
Study Group ◽  
Genotype 1 ◽  
Virus Genotype
Sign in / Sign up

Export Citation Format

Share Document